SK284534B6 - Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka - Google Patents

Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka Download PDF

Info

Publication number
SK284534B6
SK284534B6 SK455-97A SK45597A SK284534B6 SK 284534 B6 SK284534 B6 SK 284534B6 SK 45597 A SK45597 A SK 45597A SK 284534 B6 SK284534 B6 SK 284534B6
Authority
SK
Slovakia
Prior art keywords
kgf
amino acid
analog
lys
seq
Prior art date
Application number
SK455-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK45597A3 (en
Inventor
Charles F. Morris
William C. Kenney
Bao-Lu Chen
Eric W. Hsu
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of SK45597A3 publication Critical patent/SK45597A3/sk
Publication of SK284534B6 publication Critical patent/SK284534B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK455-97A 1994-10-13 1995-10-12 Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka SK284534B6 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32347594A 1994-10-13 1994-10-13
US32334094A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/IB1995/000971 WO1996011949A2 (en) 1994-10-13 1995-10-12 Analogs of keratinocyte growth factor

Publications (2)

Publication Number Publication Date
SK45597A3 SK45597A3 (en) 1999-02-11
SK284534B6 true SK284534B6 (sk) 2005-06-02

Family

ID=27406268

Family Applications (2)

Application Number Title Priority Date Filing Date
SK455-97A SK284534B6 (sk) 1994-10-13 1995-10-12 Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka
SK431-97A SK43197A3 (en) 1994-10-13 1995-10-12 Method of treating diabetes mellitus using kgf

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK431-97A SK43197A3 (en) 1994-10-13 1995-10-12 Method of treating diabetes mellitus using kgf

Country Status (23)

Country Link
EP (2) EP0785948B1 (cs)
JP (2) JP4426646B2 (cs)
KR (1) KR100278597B1 (cs)
CN (1) CN1168678A (cs)
AT (2) ATE342278T1 (cs)
AU (1) AU3707795A (cs)
BG (2) BG101392A (cs)
BR (2) BR9509269A (cs)
CA (2) CA2201940C (cs)
CZ (3) CZ98197A3 (cs)
DE (2) DE69535264T2 (cs)
DK (2) DK0785948T3 (cs)
EE (2) EE03975B1 (cs)
ES (2) ES2196082T3 (cs)
FI (2) FI971420A0 (cs)
HU (2) HUT78050A (cs)
NO (2) NO318761B1 (cs)
NZ (2) NZ505502A (cs)
PL (2) PL320484A1 (cs)
PT (2) PT804479E (cs)
SI (2) SI0804479T1 (cs)
SK (2) SK284534B6 (cs)
WO (2) WO1996011950A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647732B2 (en) 1989-01-31 1994-03-31 Stuart A. Aaronson DNA encoding a growth factor specific for epithelial cells
SK153295A3 (en) 1993-06-29 1996-11-06 Chiron Corp A truncated keratinocyte growth factor (kgf) having increased biological activity
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
DE122006000019I1 (de) * 1994-10-13 2006-06-29 Amgen Inc Methode zur reinigung von Keratinocyten-Wachstumsfaktoren
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
DE69603269T3 (de) * 1995-04-27 2007-02-22 Coöperatie Cosun U.A. Derivate von inulin
EP1473366A1 (en) * 1996-10-15 2004-11-03 Amgen Inc. Keratinocyte growth factor-2 products
ATE263239T1 (de) * 1996-10-15 2004-04-15 Amgen Inc Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
ES2297889T3 (es) 1997-07-14 2008-05-01 Bolder Biotechnology, Inc. Derivados de hormona de crecimiento y proteinas relacionadas.
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
WO1999032135A1 (en) 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6242666B1 (en) * 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
ES2373093T3 (es) * 1999-01-14 2012-01-31 Bolder Biotechnology, Inc. Métodos para preparar proteínas que contienen restos de cisteína libres.
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
WO2002062842A1 (en) * 2001-02-06 2002-08-15 Merck Patent Gmbh Modified keratinocyte growth factor (kgf) with reduced immunogenicity
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
JP2005500390A (ja) * 2001-08-21 2005-01-06 カイロン コーポレイション Ｋｇｆポリペプチド組成物
EP1827483B1 (en) 2004-12-15 2014-07-02 Swedish Orphan Biovitrum AB (publ) Therapeutic formulations of keratinocyte growth factor
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
CA1306456C (en) * 1988-07-27 1992-08-18 Marjan International Pty. Ltd. Carpet stretcher
AU647732B2 (en) * 1989-01-31 1994-03-31 Stuart A. Aaronson DNA encoding a growth factor specific for epithelial cells
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
RU2146148C1 (ru) * 1993-03-26 2000-03-10 Амген Инк. Терапевтическое применение фактора роста кератиноцитов (фрк)
US5348563A (en) * 1993-06-29 1994-09-20 Honeywell Inc. Air purifying apparatus
SK153295A3 (en) * 1993-06-29 1996-11-06 Chiron Corp A truncated keratinocyte growth factor (kgf) having increased biological activity
GB9315501D0 (en) * 1993-07-27 1993-09-08 Ici Plc Surfactant compositions
WO1995003831A1 (en) * 1993-08-02 1995-02-09 Prizm Pharmaceuticals, Inc. Monogenous preparations of cytotoxic conjugates

Also Published As

Publication number Publication date
DE69535264D1 (de) 2006-11-23
JPH10507193A (ja) 1998-07-14
NZ335109A (en) 2000-08-25
BG101408A (bg) 1997-12-30
SK43197A3 (en) 1999-03-12
EE9700225A (et) 1998-02-16
CZ297329B6 (cs) 2006-11-15
EP0804479B1 (en) 2006-10-11
BG101392A (en) 1997-10-31
NZ505502A (en) 2005-01-28
FI971420L (fi) 1997-04-04
AU3708395A (en) 1996-05-06
PT785948E (pt) 2003-09-30
PT804479E (pt) 2007-02-28
JP4216329B2 (ja) 2009-01-28
JP4426646B2 (ja) 2010-03-03
FI971420A7 (fi) 1997-04-04
NO971568L (no) 1997-06-12
DE69530403T2 (de) 2003-10-30
SI0785948T1 (en) 2003-08-31
SI0804479T1 (sl) 2006-12-31
FI971536A0 (fi) 1997-04-11
CA2201940C (en) 2009-05-12
HUT78058A (hu) 1999-07-28
FI971536L (fi) 1997-06-09
WO1996011949A2 (en) 1996-04-25
CA2202075A1 (en) 1996-04-25
PL320484A1 (en) 1997-09-29
SK45597A3 (en) 1999-02-11
ES2196082T3 (es) 2003-12-16
ES2273338T3 (es) 2007-05-01
CA2202075C (en) 2003-12-09
DK0804479T3 (da) 2007-01-29
CZ297328B6 (cs) 2006-11-15
WO1996011950A1 (en) 1996-04-25
ATE237633T1 (de) 2003-05-15
NO971568D0 (no) 1997-04-04
BR9509329A (pt) 1997-10-14
CZ105097A3 (cs) 1998-10-14
EE03975B1 (et) 2003-02-17
PL319784A1 (en) 1997-08-18
FI971420A0 (fi) 1997-04-04
CZ98197A3 (cs) 1998-11-11
FI120040B (fi) 2009-06-15
KR100278597B1 (ko) 2001-01-15
AU681546B2 (en) 1997-08-28
PL182888B1 (pl) 2002-03-29
WO1996011949A3 (en) 1996-12-12
EP0785948B1 (en) 2003-04-16
HU226168B1 (en) 2008-05-28
CN1168678A (zh) 1997-12-24
DK0785948T3 (da) 2003-08-04
NO971566L (no) 1997-04-14
AU3707795A (en) 1996-05-06
CA2201940A1 (en) 1996-04-25
NO318761B1 (no) 2005-05-02
ATE342278T1 (de) 2006-11-15
JPH10507080A (ja) 1998-07-14
DE69530403D1 (de) 2003-05-22
BG63167B1 (bg) 2001-05-31
EP0785948A1 (en) 1997-07-30
BR9509269A (pt) 1997-12-23
DE69535264T2 (de) 2007-02-01
EP0804479A1 (en) 1997-11-05
EE9700081A (et) 1997-10-15
HUT78050A (hu) 1999-07-28
NO971566D0 (no) 1997-04-04

Similar Documents

Publication Publication Date Title
SK284534B6 (sk) Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka
KR100334739B1 (ko) 절단된신경교세포주-유래신경영양성인자단백질산물
IL196645A (en) Using the Hyperglycosylic Erythropoietin Analog to prepare a pharmaceutical composition to raise and maintain hematocrit level
US6191106B1 (en) Muteins of epidermal growth factor exhibiting enhanced binding at low pH
US5158935A (en) Human epidermal growth factor having substitution at position 11
CA2202390C (en) Keratinocyte growth factor analogs
US5858977A (en) Method of treating diabetes mellitus using KGF
SK43097A3 (en) Method for purifying keratinocyte growth factors
RU2198180C2 (ru) Аналог природного фактора роста кератиноцитов (варианты), фармацевтическая композиция, рекомбинантная молекула нуклеиновой кислоты, кодирующая аналог, экспрессионный вектор, штамм e.coli, трансформированный вектором, способ получения аналога и способ стимулирования образования нефибробластных эпителиальных клеток
AU745815B2 (en) Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
AU5068502A (en) Analogs of keratinocyte growth factor
CN1169733A (zh) 角化细胞生长因子的类似物
PL184188B1 (pl) Sposób stymulacji produkcji niefibroblastowych komórek nabłonkowych
CN1169732A (zh) 角质细胞生长因子类似物
MXPA01003867A (en) Methods and compositions for the prevention and treatment of anemia

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: BIOVITRUM AB (PUBL), SE-112 76 STOCKHOLM, SE

Free format text: FORMER OWNER: AMGEN INC., THOUSAND OAKS, CA, US

Effective date: 20090616

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20111012